![Chris Moreau](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chris Moreau
Chief Executive Officer at
GREY MATTERS HEALTH INC.
Net worth: 67 367 $ as of 30/05/2026
Profile
Christopher Joseph Moreau is currently Chief Executive Officer & Director at Grey Matters Health, Inc. since 2020.
Formerly, Mr. Moreau was Director at First Responder Technologies, Inc. from 2019 to 2020, President & Chief Executive Officer at Nash Pharmaceuticals, Inc. from 2017 to 2018, President, CEO, Director & Head-Investor Relations at Luminor Medical Technologies, Inc. from 2011 to 2015, and President at Advansis Capital Corp.
from 2004 to 2005.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 13/11/2025 | 212,515 ( 3.92% ) | 67 367 $ | 30/05/2026 |
Chris Moreau active positions
| Companies | Position | Start |
|---|---|---|
| GREY MATTERS HEALTH INC. | Chief Executive Officer | 28/02/2018 |
Former positions of Chris Moreau
| Companies | Position | End |
|---|---|---|
| QUEBEC HOLDINGS PEGMATITE | President | 23/07/2019 |
Nash Pharmaceuticals, Inc.
 Nash Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Chief Executive Officer | 28/02/2018 |
Luminor Medical Technologies, Inc.
 Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and development services | Chief Executive Officer | 20/04/2016 |
Advansis Capital Corp. | President | 31/10/2005 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
22
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Luminor Medical Technologies, Inc.
Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and development services | Commercial Services |
Advansis Capital Corp. | |
Algernon Pharmaceuticals, Inc.
 Algernon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage, drug development and repurposing company | Health Technology |
First Responder Technologies, Inc.
 First Responder Technologies, Inc. Aerospace & DefenseElectronic Technology Manufactures weapon detection devices | Electronic Technology |
Nash Pharmaceuticals, Inc.
Nash Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Chris Moreau
